MedCon 2024, co-sponsored by the FDA

Back to MedCon Agenda 2024

April 25, 2024


2:20 pm


3:40 pm

Medical Device Sterilization Sustainability: EPA’s New Rule, FDA Initiatives, and Industry’s Challenges

Plenary Session

Session participants will gain understanding of the EPA EtO NESHAP Rule, FDA initiatives to strengthen sterilization sustainability, challenges and considerations for industry with alternative technologies, and watchouts and risks with FDA and industry experts.


Bill Brodbeck, Senior Director, Regulatory Affairs, STERIS Corporation


Mark Leahey, President & CEO, Medical Device Manufacturers Association (MDMA)
Brian McEvoy, Senior Director Global Technologies, Steris
Clarence Murray III, Deputy Director, Division of Infection Control and Plastic and Reconstructive Surgery Devices, Office of Product Evaluation and Quality, Center for Devices and Radiological Health (CDRH), FDA
Suzanne Schwartz – Director, Office of Strategic Partnerships & Technology Innovation, Center for Devices and Radiological Health (CDRH), FDA